Aadi bioscience to present at the td cowen 44th annual healthcare conference

Los angeles , feb. 26, 2024 /prnewswire/ -- aadi bioscience, inc. (nasdaq: aadi), a biopharmaceutical company focused on developing and commercializing precision therapies for patients with mtor pathway alterations, announced today its presentation at the td cowen 44th annual healthcare conference, taking place march 4-6, 2024, in boston. dave lennon, ph.d.
AADI Ratings Summary
AADI Quant Ranking